Albarico, Nympha .

HRN: 23-60-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/26/2023
09/02/2023
APPLY TO AFFECTED AREA
1%
BID
Infected Wound
Waiting Final Action 
08/26/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/26/2023
09/16/2023
IV
600mg
Q6hour
Infected Wound
Waiting Final Action 
08/26/2023
CEFTRIAXONE 1G (VIAL)
08/26/2023
09/02/2023
IV
2g
OD
CAP-MR
Waiting Final Action 
08/26/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/26/2023
08/30/2023
PO
500mg
OD
CAP-MR
Waiting Final Action 
08/26/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/06/2023
09/12/2023
IV
600mg
Q6H
Infected Wound
Waiting Final Action 
09/13/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
09/13/2023
09/20/2023
TOPICAL
1
TID
Infected Wound, Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: